Publicaciones en colaboración con investigadores/as de AstraZeneca (United Kingdom) (13)

2023

  1. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2803-2811

  2. Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer)

    Future oncology (London, England), Vol. 19, Núm. 38, pp. 2505-2516

2022

  1. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study

    Respiratory Medicine, Vol. 200

2020

  1. ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort

    Revista Espanola de Patologia, Vol. 53, Núm. 3, pp. 140-148

2019

  1. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

    The Lancet Respiratory Medicine, Vol. 7, Núm. 1, pp. 46-59

2015

  1. A low frequency of losses in 11q chromosome is associated with better outcome and lower rate of genomic mutations in patients with chronic lymphocytic leukemia

    PLoS ONE, Vol. 10, Núm. 12

2010

  1. Extended-release quetiapine fumarate (quetiapine XR): A once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo-and active-controlled study

    International Journal of Neuropsychopharmacology, Vol. 13, Núm. 3, pp. 305-320

2008

  1. Validity and reliability of the Spanish versions of the Bech-Rafaelsen's mania and melancholia scales for bipolar disorders

    Acta Psychiatrica Scandinavica, Vol. 117, Núm. 3, pp. 207-215

2007

  1. Seasons and other factors affecting the quality of life of asthmatic children

    Journal of Investigational Allergology and Clinical Immunology, Vol. 17, Núm. 4, pp. 249-256

  2. Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD)

    Journal of Affective Disorders, Vol. 102, Núm. 1-3, pp. 93-99

  3. The "Seroquel" Outcomes Study (SOS): Efficacy and tolerability of quetiapine in a long-term, naturalistic study of patients with schizophrenia

    International Journal of Psychiatry in Clinical Practice, Vol. 11, Núm. 3, pp. 222-232

  4. The sufficiency of the HAM-D6 as an outcome instrument in the acute therapy of antidepressants in the outpatient setting

    International Journal of Psychiatry in Clinical Practice, Vol. 11, Núm. 2, pp. 146-150

2003

  1. Burden of illness of Crohn's disease in Spain

    Digestive and Liver Disease, Vol. 35, Núm. 12, pp. 853-861